当前位置: 首页 > 期刊 > 《中外医学研究》 > 2017年第3期
编号:12977903
恶性积液局部灌药疗效观察(3)
http://www.100md.com 2017年1月25日 《中外医学研究》 2017年第3期
     [3]何义富,罗会芹.恶性腹水的内科处理进展[J].临床肿瘤学杂志,2013,18(5):472-474.

    [4]葛广华,门奋勇,吴金川,等.生物制剂联合胸腔注射治疗恶性胸水疗效观察[J].临床肿瘤杂志,1998,3(2):61.

    [5] Lejeune F J.Clinical use of TNF revisited:improving penetration of anti-cancer agents by increasing vascular permeability[J].J Clin Invest,2002,110(4):433-435.

    [6] Patterson C,Perrella M A,Endeqe W O,et al.Down regulation of vascular endothelial growth factor receptors by TNFɑ in cultured human vascular endothelial cells[J].J Clin Invest,1996,98(2):490-496.

    [7] Owens M W,Grimes S R.Pleural mesothelial cell response to imflammation: tumor necrosis factor-induced mitogenesis and collagen synthesis[J].Am J Physiol,1993,265(4 Pt 1):L382-L388.

    [8] Li Q,Sun W,Yuan D,et al.Efficacy and safety of recombinant human tumor necrosis factor application for the treatment of malignant pleural effusion caused by lung cancer[J].Thorac Cancer,2016,7(1):136-139.

    [9]陳宗万.单纯香菇多糖腹腔灌注治疗恶性腹水50例[J].四川医学,2006,11(27):1148.

    [10]刘素艳,姚雪.重组人p53腺病毒注射液联合顺铂化疗治疗恶性胸腹水临床观察[J].现代预防医学,2011,38(17):3565-3568.

    (收稿日期:2016-09-28), http://www.100md.com(许辉茹 冯慧晶 杨晓玲)
上一页1 2 3